Search

Search Constraints

You searched for: Author/Creator Compagnucci, Alexandra

Search Results

1. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. Issue 9 (September 2022)

2. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial. Issue 9 (September 2022)

3. Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission. Issue 9 (September 2015)

4. Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission. Issue 9 (September 2015)

5. Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older: a PK substudy of the SMILE trial. (3rd March 2023)

6. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption. (24th April 2016)

7. HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds. (1st September 2015)

8. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption. (24th April 2016)